Toronto Stock Exchange · Healthcare
Invest in Bausch Health Companies stock from India
Indian and foreign residents can buy Bausch Health Companies (BHC) shares directly through Paasa.
By Paasa · Updated
Bausch Health Companies at a glance
- Price
- CA$8.29+CA$0.09 (1.10%)
- Market cap
- CA$3.10B
- Day range
- CA$8.12 – CA$8.41
- P/E
- -1.98
- Dividend yield
- None
- Volume
- 423.90K
- 1 month
- -5.58%
- 6 months
- +18.09%
- YTD
- -13.01%
- 1 year
- -7.48%
- 5 years
- -76.53%
Bausch Health Companies statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $10.4B | $9.6B | $8.8B | $8.1B | $8.4B |
| Gross profit | $6.4B | $6.8B | $6.2B | $5.8B | $6.0B |
| Operating income | $2.2B | $1.5B | $963.0M | $1.4B | $1.2B |
| Net income | $159.7M | −$46.0M | −$592.0M | −$212.0M | −$937.0M |
| Earnings per share | $0.43 | −$0.12 | −$1.62 | −$0.59 | −$2.61 |
| EBITDA | $3.5B | $2.8B | $2.2B | $2.9B | $3.3B |
| Total assets | $26.3B | $26.5B | $27.4B | $25.7B | $29.2B |
| Total debt | $21.2B | $21.6B | $22.4B | $20.8B | $22.7B |
| Cash and short-term investments | $1.3B | $1.2B | $947.0M | $564.0M | $582.0M |
| Shareholders' equity | −$553.0M | −$1.3B | −$1.0B | −$692.0M | −$106.0M |
| Operating cash flow | $1.4B | $1.6B | $1.0B | −$728.0M | $1.4B |
| Free cash flow | $974.8M | $1.3B | $760.0M | −$996.0M | $1.1B |
| Capital expenditure | −$403.9M | −$340.0M | −$272.0M | −$268.0M | −$283.0M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in USD; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Curaleaf | CURA.TO | CA$14.62 | CA$3.40B |
| Trulieve Cannabis | TRUL.CN | $16.14 | $2.74B |
| Green Thumb Industries | GTII.CN | $9.40 | $2.15B |
| Cronos | CRON.TO | CA$4.70 | CA$1.76B |
Peers as grouped by the data provider. This is not an investment recommendation.
Analyst price targets
- Low
- —
- High
- —
- Median
- —
- Consensus
- —
Ratings: 7 buy · 11 hold · 2 sell. Consensus: Hold.
Published sell-side 12-month targets in CAD, aggregated by the data provider. They are not Paasa's view and not a forecast.
How to invest in Bausch Health Companies from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CAD when you buy.
Step 3
Search BHC and buy
Find Bausch Health Companies by name or by its ticker, BHC, and place your order.
Why invest in Bausch Health Companies from India
What Bausch Health Companies does
Bausch Health Companies Inc. is a global healthcare enterprise dedicated to the creation, production, and sale of a diverse array of pharmaceutical, medical device, and over-the-counter items. Its primary therapeutic focus areas include eye health, digestive system issues, and dermatological conditions. Bausch Health Companies operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Bausch Health Companies stock from India?
Yes. Indian residents and NRIs can buy Bausch Health Companies (BHC) shares directly through Paasa. Bausch Health Companies is listed on the Toronto Stock Exchange, in the Drug Manufacturers - Specialty & Generic industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Bausch Health Companies shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CAD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.